Tempus AI (TEM) stock rose 2% after Piper Sandler upgraded it to Overweight with a $76 target, citing Personalis deal and FDA approval as catalysts. The post Piper Sandler Boosts Tempus AI (TEM) Stock Rating to Overweight with $76 Target appeared first on Blockonomi.